N/A Completed N=46 Randomized Triple-blind Other

Feasibility of the BREATHE Asthma Intervention Trial

Asthma Chronic · Health Behavior

Source: ClinicalTrials.gov NCT03036267 ↗

Enrolled (actual)

Serious AEs

—

Results posted

Dec 2021

Primary outcomePrimary: Asthma Control Questionnaire — 2.34 score on a scale

Summary

Asthma rates are high and asthma control is greatly reduced in Black, Medicaid-insured adults, due in part to their poor adherence to inhaled corticosteroids (ICS), which in turn may be due to erroneous health beliefs about asthma and negative beliefs regarding ICS. A brief shared decision-making intervention for use by primary care providers in Federally Qualified Health Centers (FQHCs) has the potential to be a novel avenue to greatly improve asthma control in this high-risk patient group.

Outcome Measures

Outcome	Result	p-value
PRIMARY Asthma Control Questionnaire	2.34	—

Eligibility Criteria

The intervention trial will be informed by focus groups

Focus Group Inclusion Criteria:

Adult patients with persistent asthma or loved ones of adult patients with persistent asthma (prescribed ICS regardless of whether they are using ICS or not) receiving care at the participating FQHCs

Focus Group Exclusion Criteria:

Patients with persistent asthma or loved ones of patients with persistent asthma under they age of 18 OR NOT prescribed ICS or NOT receiving care at the participating FQHCs

Intervention Inclusion Criteria:

Patients must be:

Adults (18 years of age or older)
PCP-diagnosed persistent asthma
Currently prescribed ICS
Receiving asthma care at participating FQHCs
Who screen positive for uncontrolled asthma
Have erroneous personal health and/or negative ICS beliefs

Intervention Exclusion Criteria:

Participation in focus groups during the development phase
Non-English speaking
Serious mental health conditions (e.g., psychosis) that preclude completion of study procedures or confound analyses

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03036267). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.